Jeroen Mattijs Bezemer

This inventor holds 8 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignees: Biolex Therapeutics, Inc., Chienna B.v., Isotis N.v.. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeroen Mattijs Bezemer. Retrieved from https://idiyas.com/inventor/jeroen-mattijs-bezemer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8

% Patents Active = 50.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 109(Granted Patents)

Company Filing History:

3 out of 16

Biolex Therapeutics, Inc.

Years Active: 2002-2012

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8163307 - Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof (2012-04-24),

2. 7867518 - Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof (2011-01-11),

3. 7736674 - Controlled release compositions for interferon based on PEGT/PBT block copolymers (2010-06-15),

4. 7226612 - Coating for medical devices (2007-06-05),

5. 6835391 - Poly (ether ester amide) and poly (ether ester urethane) copolymers (2004-12-28),

6. 6730721 - Molding of a polymer (2004-05-04),

7. 6685957 - Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique (2004-02-03),

8. 6500193 - Sutures (2002-12-31),

Title: Jeroen Mattijs Bezemer: Innovator in Pharmaceutical Compositions

Introduction

Jeroen Mattijs Bezemer is a notable inventor hailing from Utrecht, Netherlands. With a remarkable portfolio of 8 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions for active compounds.

Latest Patents

Bezemer's latest inventions focus on controlled release compositions for interferons using PEGT/PBT block copolymers. These inventions disclose pharmaceutical compositions designed for the controlled release of relatively toxic active compounds, specifically targeting bioactive proteins from the class of interferons. The compositions feature biodegradable block copolymers made from poly(ethylene glycol) terephthalate (PEGT) and poly(butylene terephthalate) (PBT). They can be presented in various forms, including injectable microparticles, self-gelling injectable liquids, or solid implants. Moreover, Bezemer’s work includes a pharmaceutical kit that comprises these compositions, along with methods for preparing them and their associated pharmaceutical uses.

Career Highlights

Jeroen has built a commendable career, working for prominent companies in the pharmaceutical industry such as Chienna B.V. and Biolex Therapeutics, Inc. Through his roles, he has contributed to the intersection of innovation and practical application in drug development.

Collaborations

Throughout his career, Bezemer has collaborated with other talented professionals, including Anne Chantal Bechet and Riemke Van Dijkhuizen-Radersma. Their teamwork exemplifies the collaborative spirit that drives progress in the field of pharmaceutical innovations.

Conclusion

Jeroen Mattijs Bezemer stands out as a significant inventor in the realm of pharmaceuticals. His innovative approaches to controlled release systems underscore his commitment to improving healthcare solutions and enhancing the efficacy of drug delivery systems. As the landscape of pharmaceutical inventions continues to evolve, Bezemer's contributions will undoubtedly play a pivotal role in advancing medical research and patient care.

Profile summary based on public USPTO records.